PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
- PMID: 27128907
- PMCID: PMC4881456
- DOI: 10.3390/ijms17050630
PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
Abstract
Recent reports suggest a role for the Patatin-like phospholipase domain-containing protein 3 (PNPLA3) in the pathology of non-alcoholic fatty liver disease (NAFLD). Lipid deposition in the liver seems to be a critical process in the pathogenesis of NAFLD. The aim of the present work was to evaluate the association between the liver PNPLA3 expression, key genes of lipid metabolism, and the presence of NAFLD in morbidly obese women. We used real-time polymerase chain reaction (PCR) analysis to analyze the hepatic expression of PNPLA3 and lipid metabolism-related genes in 55 morbidly obese subjects with normal liver histology (NL, n = 18), simple steatosis (SS, n = 20), and non-alcoholic steatohepatitis (NASH, n = 17). Liver biopsies were collected during bariatric surgery. We observed that liver PNPLA3 expression was increased in NAFLD than in NL. It was also upregulated in SS than in NL. Interestingly, we found that the expression of PNPLA3 was significantly higher in severe than mild SS group. In addition, the expression of the transcription factors LXRα, PPARα, and SREBP2 was positively correlated with PNPLA3 liver expression. Regarding rs738409 polymorphism, GG genotype was positive correlated with the presence of NASH. In conclusion, our results show that PNPLA3 could be related to lipid accumulation in liver, mainly in the development and progression of simple steatosis.
Keywords: PNPLA3; fatty acid metabolism; morbid obesity; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; simple steatosis.
Figures

Similar articles
-
PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.Surg Obes Relat Dis. 2015 Jul-Aug;11(4):888-94. doi: 10.1016/j.soard.2014.07.016. Epub 2014 Aug 1. Surg Obes Relat Dis. 2015. PMID: 25240529
-
Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.Int J Mol Sci. 2014 Dec 2;15(12):22173-87. doi: 10.3390/ijms151222173. Int J Mol Sci. 2014. PMID: 25474087 Free PMC article.
-
PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.Surg Obes Relat Dis. 2016 Dec;12(10):1838-1846. doi: 10.1016/j.soard.2016.06.004. Epub 2016 Jul 1. Surg Obes Relat Dis. 2016. PMID: 27576208
-
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).Nutrients. 2017 Dec 29;10(1):29. doi: 10.3390/nu10010029. Nutrients. 2017. PMID: 29286303 Free PMC article. Review.
-
Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis.Sci Rep. 2015 Mar 20;5:9284. doi: 10.1038/srep09284. Sci Rep. 2015. PMID: 25791171 Free PMC article. Review.
Cited by
-
Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review).Exp Ther Med. 2020 Nov;20(5):26. doi: 10.3892/etm.2020.9154. Epub 2020 Aug 28. Exp Ther Med. 2020. PMID: 32934691 Free PMC article. Review.
-
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.Medicine (Baltimore). 2019 Feb;98(7):e14324. doi: 10.1097/MD.0000000000014324. Medicine (Baltimore). 2019. PMID: 30762732 Free PMC article.
-
NAFLD: Is There Anything New under the Sun?Int J Mol Sci. 2017 Sep 12;18(9):1955. doi: 10.3390/ijms18091955. Int J Mol Sci. 2017. PMID: 28895919 Free PMC article.
-
Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer.Cancers (Basel). 2019 Oct 23;11(11):1626. doi: 10.3390/cancers11111626. Cancers (Basel). 2019. PMID: 31652837 Free PMC article. Review.
-
Lipidomic characterisation discovery for coronary heart disease diagnosis based on high-throughput ultra-performance liquid chromatography and mass spectrometry.RSC Adv. 2018 Jan 2;8(2):647-654. doi: 10.1039/c7ra09353e. eCollection 2018 Jan 2. RSC Adv. 2018. PMID: 35538954 Free PMC article.
References
-
- Lonardo A., Bellentani S., Argo C.K., Ballestri S., Byrne C.D., Caldwell S.H., Cortez-Pinto H., Grieco A., Machado M.V., Miele L., et al. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Dig. Liver Dis. 2015;47:997–1006. doi: 10.1016/j.dld.2015.08.004. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical